Keratoconus Treatment Market

ID: MRFR/HC/2574-CR
153 Pages
Vikita Thakur
Last Updated: May 15, 2026
Keratoconus Treatment Market Research Report Information by Keratoconus Type (Corneal Hydrops, Forme Fruste Keratoconus, Posterior Keratoconus, Keratoglobus, Pellucid Marginal Degeneration), Treatment Type (Lenses, Surgery, Corneal Cross-Linking), End User (Eye Clinics, Hospitals), and Region(Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2035
Keratoconus Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)3.7%
2024 Market Size$ 321.48 Million
2025 Market Size$ 333.38 Million
2035 Market Size$ 479.52 Million
Key Players
Avedro
Bausch + Lomb
Alcon
Carl Zeiss
CooperVision
Menicon
Opportunities
  • Rising Geriatric Population
  • Growing Awareness and Education
  • Increasing Prevalence of Keratoconus
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Keratoconus Treatment Market, BY Treatment Type (USD Million)
      1. 4.1.1 Corneal Cross-Linking
      2. 4.1.2 Intacs
      3. 4.1.3 Scleral Lenses
      4. 4.1.4 Topography-Guided Treatment
      5. 4.1.5 Pharmaceuticals
    2. 4.2 Keratoconus Treatment Market, BY Patient Demographics (USD Million)
      1. 4.2.1 Age Group
      2. 4.2.2 Gender
      3. 4.2.3 Socioeconomic Status
      4. 4.2.4 Geographic Location
      5. 4.2.5 Severity of Condition
    3. 4.3 Keratoconus Treatment Market, BY End User (USD Million)
      1. 4.3.1 Hospitals
      2. 4.3.2 Ophthalmology Clinics
      3. 4.3.3 Ambulatory Surgical Centers
      4. 4.3.4 Optometry Practices
      5. 4.3.5 Research Institutions
    4. 4.4 Keratoconus Treatment Market, BY Distribution Channel (USD Million)
      1. 4.4.1 Direct Sales
      2. 4.4.2 Online Sales
      3. 4.4.3 Third-Party Distributors
      4. 4.4.4 Healthcare Providers
      5. 4.4.5 Pharmacies
    5. 4.5 Keratoconus Treatment Market, BY Technology (USD Million)
      1. 4.5.1 Laser-Assisted Techniques
      2. 4.5.2 Non-Invasive Techniques
      3. 4.5.3 Diagnostic Imaging Technologies
      4. 4.5.4 Biomaterials
      5. 4.5.5 Artificial Intelligence
    6. 4.6 Keratoconus Treatment Market, BY Region (USD Million)
      1. 4.6.1 North America
        1. 4.6.1.1 US
        2. 4.6.1.2 Canada
      2. 4.6.2 Europe
        1. 4.6.2.1 Germany
        2. 4.6.2.2 UK
        3. 4.6.2.3 France
        4. 4.6.2.4 Russia
        5. 4.6.2.5 Italy
        6. 4.6.2.6 Spain
        7. 4.6.2.7 Rest of Europe
      3. 4.6.3 APAC
        1. 4.6.3.1 China
        2. 4.6.3.2 India
        3. 4.6.3.3 Japan
        4. 4.6.3.4 South Korea
        5. 4.6.3.5 Malaysia
        6. 4.6.3.6 Thailand
        7. 4.6.3.7 Indonesia
        8. 4.6.3.8 Rest of APAC
      4. 4.6.4 South America
        1. 4.6.4.1 Brazil
        2. 4.6.4.2 Mexico
        3. 4.6.4.3 Argentina
        4. 4.6.4.4 Rest of South America
      5. 4.6.5 MEA
        1. 4.6.5.1 GCC Countries
        2. 4.6.5.2 South Africa
        3. 4.6.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Avedro (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Bausch + Lomb (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Alcon (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Carl Zeiss (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 CooperVision (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Menicon (JP)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 EssilorLuxottica (FR)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Johnson & Johnson (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 KeraSoft (GB)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports

Keratoconus Treatment Market Segmentation

Keratoconus Treatment Market By Treatment Type (USD Million, 2025-2035)

  • Corneal Cross-Linking
  • Intacs
  • Scleral Lenses
  • Topography-Guided Treatment
  • Keratoconus Treatment Markets

Keratoconus Treatment Market By Patient Demographics (USD Million, 2025-2035)

  • Age Group
  • Gender
  • Socioeconomic Status
  • Geographic Location
  • Severity of Condition

Keratoconus Treatment Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgical Centers
  • Optometry Practices
  • Research Institutions

Keratoconus Treatment Market By Distribution Channel (USD Million, 2025-2035)

  • Direct Sales
  • Online Sales
  • Third-Party Distributors
  • Keratoconus Treatment Market Providers
  • Pharmacies

Keratoconus Treatment Market By Technology (USD Million, 2025-2035)

  • Laser-Assisted Techniques
  • Non-Invasive Techniques
  • Diagnostic Imaging Technologies
  • Biomaterials
  • Artificial Intelligence
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.